These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

316 related items for PubMed ID: 14575221

  • 1. ACE inhibitors and beta blockers in chronic congestive cardiac failure: therapeutic basis.
    Manoria PC, Manoria P.
    J Indian Med Assoc; 2003 May; 101(5):311-2, 315. PubMed ID: 14575221
    [Abstract] [Full Text] [Related]

  • 2. Pharmacogenetic interactions between angiotensin-converting enzyme inhibitor therapy and the angiotensin-converting enzyme deletion polymorphism in patients with congestive heart failure.
    McNamara DM, Holubkov R, Postava L, Janosko K, MacGowan GA, Mathier M, Murali S, Feldman AM, London B.
    J Am Coll Cardiol; 2004 Nov 16; 44(10):2019-26. PubMed ID: 15542286
    [Abstract] [Full Text] [Related]

  • 3. Mechanistic and clinical rationales for using beta-blockers in heart failure.
    Bristow MR.
    J Card Fail; 2000 Jun 16; 6(2 Suppl 1):8-14. PubMed ID: 10908093
    [Abstract] [Full Text] [Related]

  • 4. Angiotensin II receptor antagonists and heart failure: angiotensin-converting-enzyme inhibitors remain the first-line option.
    Prescrire Int; 2005 Oct 16; 14(79):180-6. PubMed ID: 16285075
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pharmacologic management of heart failure: neurohormonal agents.
    Moser DK.
    Crit Care Nurs Clin North Am; 1993 Dec 16; 5(4):599-608. PubMed ID: 7905275
    [Abstract] [Full Text] [Related]

  • 7. Applying standard therapies to new targets: the use of ACE inhibitors and B-blockers for heart failure in adults with congenital heart disease.
    Vonder Muhll I, Liu P, Webb G.
    Int J Cardiol; 2004 Dec 16; 97 Suppl 1():25-33. PubMed ID: 15590076
    [Abstract] [Full Text] [Related]

  • 8. Meta-analyses of mortality and morbidity effects of an angiotensin receptor blocker in patients with chronic heart failure already receiving an ACE inhibitor (alone or with a beta-blocker).
    Dimopoulos K, Salukhe TV, Coats AJ, Mayet J, Piepoli M, Francis DP.
    Int J Cardiol; 2004 Feb 16; 93(2-3):105-11. PubMed ID: 14975535
    [Abstract] [Full Text] [Related]

  • 9. Prognostic benefit of beta-blockers in patients not receiving ACE-Inhibitors.
    Krum H, Haas SJ, Eichhorn E, Ghali J, Gilbert E, Lechat P, Packer M, Roecker E, Verkenne P, Wedel H, Wikstrand J.
    Eur Heart J; 2005 Oct 16; 26(20):2154-8. PubMed ID: 16014644
    [Abstract] [Full Text] [Related]

  • 10. Interaction of beta-blockers and angiotensin receptor blockers/ACE inhibitors in heart failure.
    Cohn JN.
    J Renin Angiotensin Aldosterone Syst; 2003 Sep 16; 4(3):137-9. PubMed ID: 14608516
    [Abstract] [Full Text] [Related]

  • 11. [Recent advances and limitations of medical treatment on heart failure].
    Momomura S.
    Kyobu Geka; 2007 Jun 16; 60(6):484-7. PubMed ID: 17564066
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. Angiotensin-converting enzyme inhibitors, beta-blockers, and mortality in systolic heart failure.
    Thornton PL, Ahmed A.
    J Am Coll Cardiol; 2004 Apr 07; 43(7):1333; author reply 1333-4. PubMed ID: 15063454
    [No Abstract] [Full Text] [Related]

  • 14. [ACE inhibitors, beta blockers, AT-1 antagonists in heart failure. Right dosage and combination].
    Fliri M.
    MMW Fortschr Med; 2002 Nov 28; 144(48):38-43. PubMed ID: 12532542
    [Abstract] [Full Text] [Related]

  • 15. [New therapeutic prospects in heart failure. ACE inhibitors and beta blockers].
    Capone A, Carfagna P, Paravati V, Bianco G, Battista M, Brandimarte C.
    Recenti Prog Med; 1999 Mar 28; 90(3):136-42. PubMed ID: 10228352
    [Abstract] [Full Text] [Related]

  • 16. Heart failure: recent advances in prevention and treatment.
    Fonarow GC.
    Rev Cardiovasc Med; 2000 Mar 28; 1(1):25-33, 54. PubMed ID: 12457149
    [Abstract] [Full Text] [Related]

  • 17. [Revised insights and therapeutic goals in the treatment of chronic heart failure].
    van Veldhuisen DJ.
    Ned Tijdschr Geneeskd; 1999 Jul 17; 143(29):1507-11. PubMed ID: 10443272
    [Abstract] [Full Text] [Related]

  • 18. Managing the patient with diabetes mellitus and heart failure: issues and considerations.
    Fonarow GC.
    Am J Med; 2004 Mar 08; 116 Suppl 5A():76S-88S. PubMed ID: 15019865
    [Abstract] [Full Text] [Related]

  • 19. Evidence-based drug treatment of heart failure.
    Wasson S, Fleming D, Reddy HK.
    Mo Med; 2005 Mar 08; 102(6):540-8; quiz 548-9. PubMed ID: 16355640
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.